Willingness to bear economic costs of measures against SARS-CoV-2 in Germany.
BMC Public Health
; 21(1): 1698, 2021 09 17.
Article
in English
| MEDLINE | ID: covidwho-1477397
ABSTRACT
BACKGROUND:
The aim of this study was to assess the willingness of the general population in Germany to bear the economic costs of measures against the spread of SARS-CoV-2.METHODS:
Repeated cross-sectional data were taken from three waves of a nationally representative survey of individuals aged 18 to 74 years (wave 8 21-22 April 2020, N = 976; wave 16 7-8 July 2020, N = 977; wave 38 9-10 March 2021). The willingness to accept a reduction of annual household income in order to bear the economic costs of the measures against SARS-CoV-2 served as outcome measure. Two-part models were used including explanatory variables on sociodemographic and (subjectively assessed) potential health hazard caused by COVID-19.RESULTS:
65.5% (61.6%; 56.9%) of respondents in wave 8 (wave 16; wave 38) were willing to accept a reduction of income, with the likelihood for accepting a reduction of income being positively associated with higher affect (i.e. emotional reaction) and presumed severity regarding COVID-19 in all three waves. The mean maximum percentage of income participants were willing to give up was 3.3% (95% CI 2.9 to 3.7%) in wave 8, 2.9% (95% CI 2.5 to 3.3%) in wave 16 and 4.3% (95% CI 3.6 to 5.0%) in wave 38, with presumed severity of COVID-19 being positively associated with this percentage in all three waves.CONCLUSIONS:
The majority of respondents indicated willingness to sacrifice income in order to bear the costs of measures against the spread of SARS-CoV-2, with the potential health hazard caused by COVID-19 being consistently associated with this willingness. However, the proportion of individuals who were willing to give up income slightly decreased throughout the pandemic.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
BMC Public Health
Journal subject:
Public Health
Year:
2021
Document Type:
Article
Affiliation country:
S12889-021-11734-4
Similar
MEDLINE
...
LILACS
LIS